Home » Trends in Immunotherapy

2022 Vol.6 No.2

Complement system as the potential therapeutic target in the management of COVID-19 patients
8 (Views) 5 (Downloads)

Complement system as the potential therapeutic target in the management of COVID-19 patients

The emerging COVID-19 caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has been raised as a global health challenge. Despite the breakthrough in the development of the COVID-19 vaccine, it still continues as a serious crisis, worldwide. The aberrant immune responses are strongly associated with the severity of the disease and an increased rate of morbidity and mortalit...

View pdf Read more →
Expressions of miR-199a-5p and miR-125b-5p and their target genes in the endometrium of recurrent implantation failure patients following in uterus infusion of autologous peripheral blood mononuclear cells
9 (Views) 5 (Downloads)

Expressions of miR-199a-5p and miR-125b-5p and their target genes in the endometrium of recurrent implantation failure patients following in uterus infusion of autologous peripheral blood mononuclear cells

Despite numerous advances in fertility techniques, some individuals experience implantation failure. One of the therapeutic approaches is the study of immunological aspects of the implantation process in recurrent implantation failure (RIF) patients. Peripheral blood mononuclear cell (PBMC) therapy and platelet-rich plasma are currently available cell therapies. The aim of this study was to det...

View pdf Read more →
Summary of COVID-19 vaccine-related erythema multiforme at Kindai University Hospital, Japan
8 (Views) 5 (Downloads)

Summary of COVID-19 vaccine-related erythema multiforme at Kindai University Hospital, Japan

The recently extended use of mRNA vaccines due to the COVID-19 pandemic has allowed the description of multiple cutaneous adverse events including local injection site reactions, urticaria, and morbilliform eruptions. COVID-19 vaccine-related cutaneous reaction patterns can be divided into type Ⅰ hypersensitivity reactions, type Ⅳ hypersensitivity reactions, autoimmune-related, and funct...

View pdf Read more →
Harnessing the crosstalk of adipocytes, autophagy, and immune cells for immunotherapy in obesity
7 (Views) 5 (Downloads)

Harnessing the crosstalk of adipocytes, autophagy, and immune cells for immunotherapy in obesity

As a self-degradative and recycling program, autophagy plays an essential role in homeostasis and life. The connection between autophagy and the status of the adipose tissue (white or beige/brown) links to metabolic diseases such as obesity, type two diabetes mellitus (T2DM). Moreover, autophagy and the renin-angiotensin physiological system play a pivotal role in metabolic syndrome, a disease ...

View pdf Read more →
The concise review of etiology, pathology, and treatment strategy of polyarteritis nodosa
8 (Views) 5 (Downloads)

The concise review of etiology, pathology, and treatment strategy of polyarteritis nodosa

Polyarteritis nodosa (PAN) is a necrotizing vasculitis that targets medium-sized muscular arteries and can involve small-sized arteries. The pathogenesis of classic PAN remains unclear, except for secondary PAN or vasculitis that is indistinguishable from PAN due to genetic abnormalities such as deficiency of adenosine deaminase 2. The histopathological characters of PAN change over time from t...

View pdf Read more →

Antioxidants: The counterstriking immunomodulators in therapeutics of oral lesions

Antioxidants are a group of natural phytochemicals found in dietary ingredients that can be utilised to treat oral lesions and diseases. They are employed as chemical compound alternatives since they have less adverse effects. The dietary antioxidants found in fruits and vegetables reduce the damage by modulating detoxification enzymes, increasing immune system, and hormone metabolism. Scientis...

7 (Views) 5 (Downloads)
View pdf Read more →

Peristomal pyoderma gangrenosum successfully treated with cyclosporine

Peristomal pyoderma gangrenosum (PPG) is an uncommon subtype of pyoderma gangrenosum. We describe a 74-year-old woman without inflammatory bowel disease (IBD) who developed PG around the jejunostomy and was successfully treated with cyclosporine. In our case, irritations by a lumbar corset and repeated sutures around the jejunostomy seemed to have caused pathergy reaction. It is noteworthy that...

7 (Views) 5 (Downloads)
View pdf Read more →

Successful combined treatment with omalizumab and tocilizumab in a case of chronic spontaneous urticaria and rheumatoid arthritis: A case report and literature review

Omalizumab is a recombinant humanized monoclonal anti-IgE antibody used to treat uncontrolled chronic spontaneous urticaria (CSU). Sometimes patients with CSU also have other autoimmune conditions. Recent studies have demonstrated the safety and efficacy of a combination treatment with omalizumab and other biologics. Here, we report the first successful treatment with omalizumab for CSU and toc...

9 (Views) 5 (Downloads)
View pdf Read more →